NO992998L - New analogues of camptotecin, use as drugs and pharmaceutical compositions containing them - Google Patents
New analogues of camptotecin, use as drugs and pharmaceutical compositions containing themInfo
- Publication number
- NO992998L NO992998L NO992998A NO992998A NO992998L NO 992998 L NO992998 L NO 992998L NO 992998 A NO992998 A NO 992998A NO 992998 A NO992998 A NO 992998A NO 992998 L NO992998 L NO 992998L
- Authority
- NO
- Norway
- Prior art keywords
- camptotecin
- drugs
- pharmaceutical compositions
- compositions containing
- new analogues
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615774A FR2757514B1 (en) | 1996-12-20 | 1996-12-20 | NOVEL CAMPTOTHECIN ANALOGS, PREPARATION METHODS, USE THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| PCT/FR1997/002218 WO1998028305A1 (en) | 1996-12-20 | 1997-12-05 | Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO992998D0 NO992998D0 (en) | 1999-06-18 |
| NO992998L true NO992998L (en) | 1999-08-18 |
| NO326464B1 NO326464B1 (en) | 2008-12-08 |
Family
ID=9498938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19992998A NO326464B1 (en) | 1996-12-20 | 1999-06-18 | Analogues of camptotecin, its use, and drug |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0946567B1 (en) |
| JP (2) | JP3576175B2 (en) |
| KR (1) | KR100516874B1 (en) |
| CN (1) | CN1097056C (en) |
| AR (1) | AR008543A1 (en) |
| AT (1) | ATE248177T1 (en) |
| AU (1) | AU734485B2 (en) |
| BR (1) | BR9714170A (en) |
| CA (1) | CA2275351C (en) |
| CZ (1) | CZ299795B6 (en) |
| DE (1) | DE69724453T2 (en) |
| DK (1) | DK0946567T3 (en) |
| ES (1) | ES2206761T3 (en) |
| FR (1) | FR2757514B1 (en) |
| HU (1) | HUP9904210A3 (en) |
| MX (1) | MXPA99005776A (en) |
| MY (1) | MY119473A (en) |
| NO (1) | NO326464B1 (en) |
| NZ (1) | NZ335939A (en) |
| PL (1) | PL188181B1 (en) |
| PT (1) | PT946567E (en) |
| RU (1) | RU2194051C2 (en) |
| UA (1) | UA57758C2 (en) |
| WO (1) | WO1998028305A1 (en) |
| ZA (1) | ZA9711129B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2790261B1 (en) * | 1999-02-26 | 2004-09-10 | Sod Conseils Rech Applic | NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS AND PROCESSES FOR THEIR PREPARATION |
| FR2768431B1 (en) * | 1997-08-29 | 2000-03-24 | Sod Conseils Rech Applic | NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS, A NEW OPTICALLY PURE SYNTHESIS INTERMEDIATE AND PROCESS FOR PREPARING THE SAME |
| US6291676B1 (en) * | 1999-03-03 | 2001-09-18 | University Of Kentucky Research Foundation | Water-soluble derivatives of camptothecin/homocamptothecin |
| US6207832B1 (en) | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| AU3455100A (en) * | 1999-05-28 | 2000-12-18 | Nippon Chemiphar Co. Ltd. | Process for the preparation of 2-halo-3-(3-quinolyl)propionic acid derivatives |
| US6372906B1 (en) | 2001-04-12 | 2002-04-16 | University Of Pittsburgh | Synthesis of silyl camptothecins and silyl homocamptothecins |
| US6723853B2 (en) | 2001-08-27 | 2004-04-20 | University Of Pittsburgh | Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins |
| AU2003225642A1 (en) * | 2002-03-01 | 2003-09-16 | Fluorous Techonologies Inc | Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs |
| AR046579A1 (en) * | 2003-11-12 | 2005-12-14 | Smithkline Beecham Corp | TOPOTECAN CRYSTAL COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE TO PREPARE IT AND ITS USE TO PREPARE SUCH PHARMACEUTICAL COMPOSITION |
| ITRM20040288A1 (en) * | 2004-06-11 | 2004-09-11 | Sigma Tau Ind Farmaceuti | USE OF 7-T-BUTOXYIMINOMETHYL CAMPTOTECIN FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF UTERUS NEOPLASIES. |
| JP2008513437A (en) * | 2004-09-21 | 2008-05-01 | ソシエテ ド コンセイユ ド ルシェルシェ エ ダアップリカーション シャンティフィック（エス．セー．エール．アー．エス．） | Novel process for the production of useful intermediates |
| CN102746314B (en) * | 2011-04-18 | 2016-07-06 | 华东师范大学 | Containing stablizing the camptothecine compounds of 7 yuan of lactonic rings, preparation method and purposes |
| CN114539292B (en) * | 2022-01-28 | 2023-08-29 | 遵义医药高等专科学校 | A novel podophyllotoxin splicing anti-tumor active molecular compound and its preparation method and application |
| CN117164601A (en) * | 2022-06-02 | 2023-12-05 | 华东师范大学 | A kind of high camptothecin small molecule and its application |
| CN121194979A (en) * | 2023-05-08 | 2025-12-23 | 甘李药业股份有限公司 | Camptothecin derivatives, linkers, ligand-drug conjugates and their pharmaceutical uses |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0615547B2 (en) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | Novel camptothecin derivative |
| US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
| BR9608639A (en) * | 1995-06-21 | 1999-06-29 | Sod Conseils Rech Applic | Camptothecin analogue compound process for preparing product compounds industry medicines pharmaceutical compositions and product use |
-
1996
- 1996-12-20 FR FR9615774A patent/FR2757514B1/en not_active Expired - Fee Related
-
1997
- 1997-05-12 UA UA99063449A patent/UA57758C2/en unknown
- 1997-12-05 MX MXPA99005776A patent/MXPA99005776A/en not_active IP Right Cessation
- 1997-12-05 RU RU99115829/04A patent/RU2194051C2/en not_active IP Right Cessation
- 1997-12-05 PL PL97334125A patent/PL188181B1/en not_active IP Right Cessation
- 1997-12-05 DK DK97950236T patent/DK0946567T3/en active
- 1997-12-05 PT PT97950236T patent/PT946567E/en unknown
- 1997-12-05 CZ CZ0220599A patent/CZ299795B6/en not_active IP Right Cessation
- 1997-12-05 HU HU9904210A patent/HUP9904210A3/en unknown
- 1997-12-05 BR BR9714170-4A patent/BR9714170A/en not_active Application Discontinuation
- 1997-12-05 ES ES97950236T patent/ES2206761T3/en not_active Expired - Lifetime
- 1997-12-05 DE DE69724453T patent/DE69724453T2/en not_active Expired - Lifetime
- 1997-12-05 JP JP52844898A patent/JP3576175B2/en not_active Expired - Fee Related
- 1997-12-05 KR KR10-1999-7005603A patent/KR100516874B1/en not_active Expired - Fee Related
- 1997-12-05 WO PCT/FR1997/002218 patent/WO1998028305A1/en not_active Ceased
- 1997-12-05 NZ NZ335939A patent/NZ335939A/en not_active IP Right Cessation
- 1997-12-05 CA CA002275351A patent/CA2275351C/en not_active Expired - Fee Related
- 1997-12-05 EP EP97950236A patent/EP0946567B1/en not_active Expired - Lifetime
- 1997-12-05 AU AU53265/98A patent/AU734485B2/en not_active Ceased
- 1997-12-05 AT AT97950236T patent/ATE248177T1/en active
- 1997-12-05 CN CN97180815A patent/CN1097056C/en not_active Expired - Fee Related
- 1997-12-10 ZA ZA9711129A patent/ZA9711129B/en unknown
- 1997-12-17 MY MYPI97006088A patent/MY119473A/en unknown
- 1997-12-19 AR ARP970106043A patent/AR008543A1/en active IP Right Grant
-
1999
- 1999-06-18 NO NO19992998A patent/NO326464B1/en not_active IP Right Cessation
-
2003
- 2003-11-26 JP JP2003395513A patent/JP2004115535A/en not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004353D0 (en) | New pyridazine derivatives and drugs containing these as active ingredients | |
| FI973039A0 (en) | Novel farnesyltransferase inhibitors, their preparation and pharmaceutical compositions containing them | |
| FI973279A0 (en) | Novel farnesyltransferase inhibitors, their preparation and pharmaceutical compositions containing them | |
| IS5409A (en) | Replacement of carboxamidothiazole, their preparation and pharmaceutical preparations containing them | |
| NO996433D0 (en) | New formulations of drugs, methods of preparation thereof and methods of use thereof | |
| NO307783B1 (en) | Quinoline derivatives such as tachykinin NK3 receptor antagonists, pharmaceutical preparations containing them and use of such derivatives | |
| EE9900546A (en) | LH-RH peptide analogs, their use and pharmaceutical compositions containing them | |
| FI973278A7 (en) | Novel farnesyltransferase inhibitors, their preparation and pharmaceutical preparations containing them | |
| NO973922D0 (en) | New taxoids, their preparation and pharmaceutical compositions containing the compounds | |
| NO955034L (en) | New substituted 1H-imidazoles and pharmaceutical compositions containing them | |
| NO20016198D0 (en) | Oral pharmaceutical compositions containing taxanes and methods of using the same in treatment | |
| HUP9900413A3 (en) | Use of coralyne derivatives, new coralyne derivatives and use thereof, pharmaceutical compositions containing these new coralyne derivatives | |
| NO308294B1 (en) | Dimethyl-3 (aryl-but-3-enyl) -amine compound as pharmaceutical compounds and their use | |
| NO984878D0 (en) | Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters | |
| NO994620D0 (en) | New 2- (iminomethyl) amino-phenyl derivatives, preparation, use as medicines and pharmaceutical compositions containing them | |
| DK1006110T3 (en) | Derivatives of acylpiperazinylpyrimidines, their preparation and use as pharmaceuticals | |
| DK0885204T3 (en) | New arylglycinamide derivatives, processes for their preparation and pharmaceutical compositions containing these compounds | |
| NO992998L (en) | New analogues of camptotecin, use as drugs and pharmaceutical compositions containing them | |
| NO305903B1 (en) | Benzonitriles and benzofluorides, drugs comprising the compounds, pharmaceutical compositions containing the compounds, and use of the compounds for the preparation of pharmaceutical preparations | |
| NO976128D0 (en) | Compounds and pharmaceutical compositions containing them | |
| NO20010031D0 (en) | Derivatives of 2-aminopyridines, their use as drugs and pharmaceutical preparations containing them | |
| NO992997D0 (en) | Promotional forms and new analogues of camptotecin, as well as their use as drugs | |
| FI943688L (en) | New 11-benzaldoxime-17beta-methoxy-27alpha-methoxy-methyl-estradiene derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| NO302368B1 (en) | Quinoxaline compounds, pharmaceutical compositions containing them, and use of the compounds for the preparation of the preparations | |
| NO308842B1 (en) | New retinoids, their use, and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |